SAN CARLOS, Calif., March 31, 2019 /PRNewswire/ -- Apexigen, Inc., a clinical-stage biopharmaceutical company, today announced the presentation of new clinical data on APX005M in combination therapy in patients with metastatic pancreatic cancer. The data are being presented in a plenary...
from PR Newswire: https://ift.tt/2VaoIPM
No comments:
Post a Comment